Ahmed Glaucoma Valve Implantation; Graft-Free Short Tunnel Small Flap Versus Scleral Patch Graft
NCT03551834 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2018-06-11
Summary
Glaucoma implants have been used for refractory glaucoma and are gaining popularity as a primary procedure in selected patients. In order to prevent tube erosion, a biologic material such as pericardium, cornea, and sclera is used as coverage over the tube. Despite this preventive measures, patch graft thinning and silicon tube exposure are still a serious complications and may occur in 1%-7% of eyes after glaucoma implantation. In this study we used a novel technique named short tunnel small flap (STSF) by tunneling the sclera without using any biological material . efficacy and safety of this technique is comparing with conventional scleral patch graft.
This randomized clinical trial, was performed at the Glaucoma Clinic of Labbafinejad Medical Center, Tehran, IRAN from September 2015 to January 2017 . The study was approved by the ethics committee at the Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran and followed the tenets of the Declaration of Helsinki. After explaining all therapeutic options and their side effects, the written consent form was obtained from all patient. 80 eyes of 80 patients with refractory glaucoma underwent AGV implantation by short tunnel small flap technique (group1) or scleral patch graft (group2) randomly. Primary outcome measure is Intraocular pressure(IOP) and Tube exposure, and secondary outcome measure is success rate that is defined as intraocular pressure (IOP) \> 5 mmHg, ≤ 21 mmHg, and IOP reduction ≥ 20% from baseline at two consecutive visits after three months, no reoperation for glaucoma. Outcome measures are compared at 1, 3 , 6 and 12 months postoperatively.
Conditions
Interventions
- OTHER
-
Conventional scleral patch graft glaucoma implantation
conventional AGV implantation by using scleral patch graft to cover the tube and prevent tube exposure
- OTHER
-
New surgical method (short tunnel small flap technique)
a novel technique named short tunnel small flap (STSF) by tunneling the sclera to pass the AGV tube without using scleral patch graft.
Sponsors & Collaborators
-
Shahid Beheshti University of Medical Sciences
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-20
- Primary Completion
- 2017-09-20
- Completion
- 2018-09-30
Countries
- Iran
Study Locations
More Related Trials
-
Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves and Second Trabeculectomy in Glaucoma Patients
NCT00665756 ·Status: UNKNOWN ·Phase: NA
-
Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma
NCT00893490 ·Status: UNKNOWN ·Phase: PHASE1
-
Effect of Subconjunctival 5-fluorouracil on the Outcome of Ahmed Valve in Neovascular Glaucoma
NCT05316142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intraluminal Stenting Versus External Ligation of Ahmed Glaucoma Valve
NCT04508881 ·Status: COMPLETED ·Phase: NA
-
Long Term Outcome After Ahmed Glaucoma Valve
NCT01741961 ·Status: COMPLETED
-
Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves
NCT01883856 ·Status: COMPLETED ·Phase: NA
-
The Results of Ahmed Valve Operations
NCT00193960 ·Status: UNKNOWN
-
Ahmed Versus Baerveldt Comparison Study
NCT00376363 ·Status: COMPLETED ·Phase: NA
-
Paul Glaucoma Implant Versus Ahmed Glaucoma Valve in Childhood Glaucoma
NCT05797350 ·Status: UNKNOWN ·Phase: NA
-
Ahmed Valve Implantation Coated With Poly Lactic -Co-glycolic Acid (PLGA) Saturated With Mitomycin-C in the Management of Adult Onset Glaucoma in Sturge Weber Syndrome
NCT04735601 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety Study of Aqueous Suppression After Ahmed Glaucoma Valve (AGV) Implantation
NCT01814514 ·Status: UNKNOWN ·Phase: PHASE2
-
The AVB Study: Prospective Study Comparing the Ahmed Valve and the Baerveldt Implant for Treating Refractory Glaucoma
NCT00940823 ·Status: COMPLETED ·Phase: NA
-
Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma
NCT02260219 ·Status: TERMINATED ·Phase: NA
-
Phaco-Trabeculotomy Vs Phaco-Trabeculectomy
NCT04683055 ·Status: COMPLETED ·Phase: NA
-
Assessment of Effectiveness Ex-Press Surgery Modification
NCT03800589 ·Status: COMPLETED ·Phase: NA
-
AGV Implantation With Ologen in Pediatric Glaucomas
NCT05014386 ·Status: UNKNOWN ·Phase: NA
-
Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma
NCT04542616 ·Status: COMPLETED ·Phase: NA
-
The Asia Primary Tube Versus Trab (TVT) Study
NCT03274024 ·Status: UNKNOWN ·Phase: NA
-
Trabeculectomy With MMC Versus Ahmed Glaucoma Implant for Treatment of Pediatric Aphakic Glaucoma
NCT00371072 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Posterior Chamber Glaucoma Drainage Device
NCT07003685 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Study on Ex-PRESS Implantation Combined With Phacoemulsification in Primary Angle-closure Glaucoma
NCT03323138 ·Status: UNKNOWN ·Phase: NA
-
Combined Phacoemulsification and Diode Laser Therapy in Chronic Angle Closure Glaucoma
NCT05576493 ·Status: UNKNOWN ·Phase: NA
-
Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves
NCT01535768 ·Status: UNKNOWN ·Phase: PHASE4
-
The American Glaucoma Society (AGS) Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)
NCT02691455 ·Status: TERMINATED ·Phase: NA
-
Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection
NCT00491712 ·Status: UNKNOWN ·Phase: NA